Navigation Links
NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit
Date:1/12/2009

Amistaff Healthcare Technology will be holding a developers summit for companies interested in integrating NurseTesting 2.0 with their software platform.

(Vocus) January 12, 2009 -- Analysts and industry-watchers believe that cloud computing is changing not just the technology landscape but also the entire nature of the business models that underpin successful software and hardware companies.

Amistaff Healthcare Technology, specifically NurseTesting 2.0, envisions the need to integrate its nationally recognized, industry leading competency testing software into various solutions. James Ostmann, Chief Nursing Officer for Amistaff states “We have put an enormous amount of time, energy, and resources into updating our clinical content, having subject matter experts from leading hospitals across the United States participate in a formal content validation process. By adhering to the Uniform Guidelines on Employee Selection Procedures outlined by the Department of Labor, Amistaff ensures that only reliable, valid, and relevant content is used during the development of its clinical products, thereby reducing the risk and liability for hospitals and staffing firms across the United States.” Amistaff’s rigorous and quality centric approach raises the bar in the healthcare industry, which translates into better-qualified healthcare professionals being hired, and thus, a safer and higher quality of care being delivered in healthcare facilities throughout the United States.

NurseTesting is fast approaching 100,000 exam completions per month, providing valuable data and analytics on

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification
2. Medical Staffing Network Selects NurseTesting.com for Screening of Healthcare Professionals Working through MSN's OneSource Vendor Management Program
3. Senior Living Provider Invites Residents to Dream. Dare. Discover!
4. Informex Invites Young Chemists to Attend InformexUSA
5. Population Health Impact Institute Invites Organizations To Serve as Test Sites for Methods Evaluation Process(TM) (MEP(TM)) Accreditation Program:
6. Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
7. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
8. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
9. The Champalimaud Foundation Invites Nominations and Applications for Its 2009 Vision Award
10. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
11. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...GINIA BEACH, Va., Dec. 2 By now, m...okeless cigarettes continue to grow in popularity....lable at the PremiumEcigarette - the new single pi... - at the amazingly low price of $14.99. ,, "Th... the e-cigarette at a very low price, before makin...
(Date:12/2/2009)... , New Directors Represent Diverse Healthc...wswire-USNewswire/ -- The membership of the Nation... its Board of Directors and reappointed four curre...a wide range of healthcare stakeholders, including...nd public and community healthcare. ,, The new...
(Date:12/2/2009)...LADELPHIA, Dec. 2 Independence Blu...its contract with Lincoln Financial Group. IBC wil...approximately 10,000 Lincoln Financial Group emplo...tion. The Lincoln plan offerings will include the ...,, "I know I speak for all of us at Independenc...
(Date:12/2/2009)...lif.Researchers from the California Institute of T...il, and for the first time, the previously mysteri...ed ubiquitin are added by enzymes called ubiquitin...Ubiquitin chains tag target proteins for destructi... "We found that ubiquitin ligases build ubiquitin ...
(Date:12/2/2009)...is the official congress of the European Associati...of the European Society of Cardiology, where techn...resented. , New case reports will be presented ...highlighting the role of this new technology. , ...iques, it is likely that non-invasive imaging will...
Breaking Medicine News(10 mins):Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:Media alert: EUROECHO 2009 2
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ...roducts and services, today announced that it will...nded September 27, 2008 after the,market close on ... Time) to discuss its second quarter results,and c...
...28 Professional Healthcare,Resources, Inc., one o...healthcare agencies based in the Washington, DC me...been named to the 2008 Homecare Elite. The,selecti...ealthcare publisher., This annual review identifi...
...ialty Pharmacy programs expand URAC,s Pharmacy,Qua...28 URAC announced that four,companies have achiev...ograms under its Pharmacy Quality Management(SM) i...his scope for the pharmacy benefit management and ...
...tion in BRCA1 Mutation Carriers , One X chromoso...romosome in women who carry mutations in the BRCA1... with a later onset of breast or ovarian cancer in...X chromosome, the cells in a woman,s body inactiva...
...-lowering statins is associated with a statistical...n (PSA) levels, according to a report in the Octob... Cancer Institute . , Previous studies examined w... association between statins and PSA level. , In...
...patients in more than 1,500 physician practices ha...ealth-care experiences, with minority patients hav...dings suggest that while all doctors should be att...nt-centered. The study, which was led by a health ...
Other Medicine News:Health News:ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 3Health News:Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs 2Health News:Also in the Oct. 28 JNCI 2Health News:Also in the Oct. 28 JNCI 3Health News:Also in the Oct. 28 JNCI 4Health News:Also in the Oct. 28 JNCI 5Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Racial and ethnic disparities detected in patient experiences 2
(Date:12/2/2009)... Cantel Medical Corp. (NY... quarter ended October 31, 2009 on December 9 befo... discuss the results at 11:00 AM ET. Participatin...Andrew A. Krakauer, President and CEO; Seth R. Seg...nior Vice President, CFO and Treasurer; and Roy K....
(Date:12/2/2009)...Newswire/ -- ALERT ALARM, a Michigan-based home an...xclusive availability of new crystal necklace medi...ce of jewelry, these personal emergency response d...cy medical response assistance. ,, (Photo: htt... ) ,, For elderly users, those with a medical c...
(Date:12/2/2009)... Dec. 2 Interleukin Gene...cal Center announced findings from a study perform...netics of osteoarthritis have been published this ...f Rheumatic Diseases and is available at http://a... Results from the study highlight importance of i...
Breaking Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 1New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 2New Analysis Examines Fraud in Both Private and Public Health Insurance Markets 50185 3HIV Patients May Have Stiffer Arteries 50183 1Many Adults With Asthma Are Skipping Flu Shots 50181 1Many Adults With Asthma Are Skipping Flu Shots 50181 2
...ORK, Nov. 5 - Top experts from the,Alzheimer,s Fou...espread,utilization of memory screenings, especial...ild and moderate dementia are not recognized,often...priate treatment and,other positive interventions.... J. Wesson Ashford,M.D., Ph.D., senior research sc...
...sented at the 13th Annual Meeting of Connective Ti...on demonstrates clinical activity and tolerabi...ith chemo-insensitive sarcom...c. (Nasdaq: KERX ) today announced that prelimina...l activity of KRX-0401 (perifosine) in patients,wi...
Other Medicine Technology:Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6
Snap-In Snap-Out®-II Alligator Grasping Forceps Insert
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Optima III 45 Noninsulated Maryland Dissector
Dolphin-Nose Dissector, dual-incision
Medicine Products: